ARTICLE | Company News
Cardiorentis, Roche deal
November 3, 2014 8:00 AM UTC
Cardiorentis will incorporate undisclosed in vitro diagnostics from Roche in the ongoing Phase III TRUE-AHF trial to characterize the therapeutic benefits of Cardiorentis' ularitide in acute decompen...